Precigen (PGEN) Short term Debt (2012 - 2023)
Precigen (PGEN) reported Short term Debt of $13.8 million for Q1 2023, up 53050.0% year-over-year from N/an in Q1 2022, and down 68.03% quarter-over-quarter from $43.2 million in Q4 2022.
Precigen (PGEN) Short term Debt (2012 - 2023) Analysis & Trends
Precigen (PGEN) has 12 years of Short term Debt data on file, last reported at $13.8 million in Q1 2023.
- Short term Debt for Q1 2023 came in at $13.8 million, up 53050.0% year-over-year; the trailing twelve-month figure through Mar 2023 was $13.8 million (up 53050.0% YoY), and the FY2022 annual result was $43.2 million, up 58304.05% from the prior year.
- Short term Debt declined to $13.8 million in Q1 2023 per PGEN's latest filing, from $43.2 million in the prior quarter.
- Over five years, Short term Debt peaked at $43.2 million in Q4 2022 and troughed at $22000.0 in Q2 2021.
- A 5-year average of $6.2 million and a median of $360000.0 in 2020 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2020 and 2022: Short term Debt plunged 98.66% in 2020, then surged 58304.05% in 2022.
- A 5-year view of Short term Debt shows it stood at $51000.0 in 2019, then soared by 605.88% to $360000.0 in 2020, then sank by 79.44% to $74000.0 in 2021, then surged by 58304.05% to $43.2 million in 2022, then slumped by 68.03% to $13.8 million in 2023.
- Business Quant data shows PGEN's Short term Debt at $13.8 million in Q1 2023, $43.2 million in Q4 2022, and $58000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 13.82 Mn |
| Dec 31, 2022 | 43.22 Mn |
| Jun 30, 2022 | 58,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 22,000.00 |
| Mar 31, 2021 | 359,000.00 |
| Dec 31, 2020 | 360,000.00 |
| Sep 30, 2020 | 421,000.00 |
| Mar 31, 2020 | 1.21 Mn |
| Dec 31, 2019 | 51,000.00 |
| Sep 30, 2019 | 31.43 Mn |
| Jun 30, 2019 | 468,000.00 |
| Mar 31, 2019 | 2.08 Mn |
| Dec 31, 2018 | 479,000.00 |
| Sep 30, 2018 | 200,000.00 |
| Jun 30, 2018 | 112,000.00 |
| Mar 31, 2018 | 321,000.00 |
| Dec 31, 2017 | 233,000.00 |